I keep thinking there's a Nobel Prize in it for whatever team either figures out the vaccine or the cocktail of drugs that neutralizes the virus, as it may be.
About a year ago—not even quite a year ago—we launched a new level three biohazard lab here at the university. Little did we suspect that only six months later it would be put to such use as it's being put to now, in terms of working on the vaccine.
We have teams of researchers who are in the vaccine race, for sure, but we also have teams of researchers working on some of the social effects of the pandemic. We know the science side is a key piece of it, but there's also the whole social science and humanist side of how you get people back to work, how you help people cope with isolation, despair, depression or the economic damage that's happening right across the country. We're very mindful of those issues. Our researchers, the ones who are not on campus and have been sent home to do their work in their living rooms and at their kitchen tables, are chomping at the bit to get back, but we continue to have the campus open for some of our research that's directly COVID-related.